Upgrades
According to Northcoast Research, the prior rating for Boeing Co BA was changed from Sell to Neutral. In the second quarter, Boeing showed an EPS of $0.82, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $240.13 and a 52-week-low of $120.99. Boeing closed at $238.85 at the end of the last trading period.
For Varonis Systems Inc VRNS, Craig-Hallum upgraded the previous rating of Hold to Buy. Varonis Systems earned $0.01 in the second quarter, compared to $0.00 in the year-ago quarter. The current stock performance of Varonis Systems shows a 52-week-high of $32.05 and a 52-week-low of $15.61. Moreover, at the end of the last trading period, the closing price was at $28.70.
Atlantic Equities upgraded the previous rating for The Goldman Sachs Group Inc GS from Underweight to Neutral. For the second quarter, Goldman Sachs Gr had an EPS of $3.08, compared to year-ago quarter EPS of $7.73. The current stock performance of Goldman Sachs Gr shows a 52-week-high of $389.43 and a 52-week-low of $287.84. Moreover, at the end of the last trading period, the closing price was at $355.87.
For ResMed Inc RMD, RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the third quarter, ResMed had an EPS of $1.68, compared to year-ago quarter EPS of $1.32. The current stock performance of ResMed shows a 52-week-high of $247.51 and a 52-week-low of $202.04. Moreover, at the end of the last trading period, the closing price was at $222.35.
According to Barclays, the prior rating for Gap Inc GPS was changed from Equal-Weight to Overweight. In the first quarter, Gap showed an EPS of $0.01, compared to $0.44 from the year-ago quarter. The current stock performance of Gap shows a 52-week-high of $15.49 and a 52-week-low of $7.22. Moreover, at the end of the last trading period, the closing price was at $10.30.
According to Barclays, the prior rating for Tapestry Inc TPR was changed from Equal-Weight to Overweight. For the third quarter, Tapestry had an EPS of $0.78, compared to year-ago quarter EPS of $0.51. The current stock performance of Tapestry shows a 52-week-high of $47.48 and a 52-week-low of $27.54. Moreover, at the end of the last trading period, the closing price was at $43.15.
Barclays upgraded the previous rating for Bath & Body Works Inc BBWI from Equal-Weight to Overweight. Bath & Body Works earned $0.33 in the first quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.55 and a 52-week-low of $30.52. Bath & Body Works closed at $37.06 at the end of the last trading period.
For American Eagle Outfitters Inc AEO, Barclays upgraded the previous rating of Equal-Weight to Overweight. In the first quarter, American Eagle Outfitters showed an EPS of $0.17, compared to $0.16 from the year-ago quarter. The current stock performance of American Eagle Outfitters shows a 52-week-high of $17.09 and a 52-week-low of $9.46. Moreover, at the end of the last trading period, the closing price was at $14.05.
See all analyst ratings upgrades.
Downgrades
Argus Research downgraded the previous rating for Canadian National Railway Co CNI from Buy to Hold. In the second quarter, Canadian National Railway showed an EPS of $1.31, compared to $1.51 from the year-ago quarter. The current stock performance of Canadian National Railway shows a 52-week-high of $129.85 and a 52-week-low of $103.81. Moreover, at the end of the last trading period, the closing price was at $121.23.
According to RBC Capital, the prior rating for New Relic Inc NEWR was changed from Outperform to Sector Perform. New Relic earned $0.43 in the first quarter, compared to $0.26 in the year-ago quarter. The stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. At the end of the last trading period, New Relic closed at $83.98.
According to Hovde Group, the prior rating for Valley National Bancorp VLY was changed from Outperform to Market Perform. For the second quarter, Valley Ntl had an EPS of $0.28, compared to year-ago quarter EPS of $0.32. The current stock performance of Valley Ntl shows a 52-week-high of $13.06 and a 52-week-low of $6.38. Moreover, at the end of the last trading period, the closing price was at $10.26.
William Blair downgraded the previous rating for Symbotic Inc SYM from Outperform to Market Perform. For the third quarter, Symbotic had an EPS of $0.07, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $64.14 and a 52-week-low of $8.75. At the end of the last trading period, Symbotic closed at $63.54.
Citigroup downgraded the previous rating for Reata Pharmaceuticals Inc RETA from Buy to Neutral. For the first quarter, Reata Pharmaceuticals had an EPS of $1.81, compared to year-ago quarter EPS of $1.33. At the moment, the stock has a 52-week-high of $167.24 and a 52-week-low of $18.47. Reata Pharmaceuticals closed at $165.58 at the end of the last trading period.
According to Loop Capital, the prior rating for MaxLinear Inc MXL was changed from Buy to Hold. For the second quarter, MaxLinear had an EPS of $0.34, compared to year-ago quarter EPS of $1.11. The current stock performance of MaxLinear shows a 52-week-high of $43.66 and a 52-week-low of $22.25. Moreover, at the end of the last trading period, the closing price was at $24.67.
According to DA Davidson, the prior rating for Symbotic Inc SYM was changed from Buy to Neutral. For the third quarter, Symbotic had an EPS of $0.07, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $64.14 and a 52-week-low of $8.75. At the end of the last trading period, Symbotic closed at $63.54.
For New Relic Inc NEWR, Baird downgraded the previous rating of Outperform to Neutral. New Relic earned $0.43 in the first quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. New Relic closed at $83.98 at the end of the last trading period.
According to Wells Fargo, the prior rating for Chinook Therapeutics Inc KDNY was changed from Overweight to Equal-Weight. Chinook Therapeutics earned $0.85 in the first quarter, compared to $0.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.54 and a 52-week-low of $17.72. Chinook Therapeutics closed at $39.18 at the end of the last trading period.
According to Cantor Fitzgerald, the prior rating for Rivian Automotive Inc RIVN was changed from Overweight to Neutral. Rivian Automotive earned $1.25 in the first quarter, compared to $1.43 in the year-ago quarter. The stock has a 52-week-high of $40.86 and a 52-week-low of $11.68. At the end of the last trading period, Rivian Automotive closed at $27.64.
B of A Securities downgraded the previous rating for Apellis Pharmaceuticals Inc APLS from Buy to Neutral. In the second quarter, Apellis Pharmaceuticals showed an EPS of $1.02, compared to $1.46 from the year-ago quarter. The current stock performance of Apellis Pharmaceuticals shows a 52-week-high of $94.75 and a 52-week-low of $24.97. Moreover, at the end of the last trading period, the closing price was at $25.75.
Deutsche Bank downgraded the previous rating for ZoomInfo Technologies Inc ZI from Buy to Hold. In the second quarter, ZoomInfo Technologies showed an EPS of $0.26, compared to $0.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.85 and a 52-week-low of $20.33. ZoomInfo Technologies closed at $25.57 at the end of the last trading period.
For New Relic Inc NEWR, Credit Suisse downgraded the previous rating of Outperform to Neutral. For the first quarter, New Relic had an EPS of $0.43, compared to year-ago quarter EPS of $0.26. At the moment, the stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. New Relic closed at $83.98 at the end of the last trading period.
Citigroup downgraded the previous rating for The Estee Lauder Companies Inc EL from Buy to Neutral. Estee Lauder Cos earned $0.47 in the third quarter, compared to $1.90 in the year-ago quarter. The stock has a 52-week-high of $284.27 and a 52-week-low of $171.93. At the end of the last trading period, Estee Lauder Cos closed at $180.00.
According to Barclays, the prior rating for Reata Pharmaceuticals Inc RETA was changed from Overweight to Equal-Weight. In the first quarter, Reata Pharmaceuticals showed an EPS of $1.81, compared to $1.33 from the year-ago quarter. The stock has a 52-week-high of $167.24 and a 52-week-low of $18.47. At the end of the last trading period, Reata Pharmaceuticals closed at $165.58.
Keefe, Bruyette & Woods downgraded the previous rating for SoFi Technologies Inc SOFI from Market Perform to Underperform. In the second quarter, SoFi Techs showed an EPS of $0.06, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.70 and a 52-week-low of $4.25. SoFi Techs closed at $11.45 at the end of the last trading period.
For Brown & Brown Inc BRO, Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the second quarter, Brown & Brown showed an EPS of $0.68, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $72.99 and a 52-week-low of $52.82. At the end of the last trading period, Brown & Brown closed at $70.45.
For Eastman Chemical Co EMN, Piper Sandler downgraded the previous rating of Overweight to Neutral. For the second quarter, Eastman Chemical had an EPS of $1.99, compared to year-ago quarter EPS of $2.83. At the moment, the stock has a 52-week-high of $102.12 and a 52-week-low of $69.91. Eastman Chemical closed at $85.58 at the end of the last trading period.
See all analyst ratings downgrades.
Initiations
RF Lafferty initiated coverage on Polestar Automotive Holding UK PLC PSNY with a Buy rating. The price target for Polestar Automotive is set to $9.00. For the first quarter, Polestar Automotive had an EPS of $0.01, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $10.11 and a 52-week-low of $3.14. Polestar Automotive closed at $4.48 at the end of the last trading period.
With an Overweight rating, Cantor Fitzgerald initiated coverage on Health Catalyst Inc HCAT. The price target seems to have been set at $16.00 for Health Catalyst. In the first quarter, Health Catalyst showed an EPS of $0.05, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $18.28 and a 52-week-low of $6.41. At the end of the last trading period, Health Catalyst closed at $14.03.
Seaport Global initiated coverage on TopBuild Corp BLD with a Buy rating. In the first quarter, TopBuild showed an EPS of $4.36, compared to $3.50 from the year-ago quarter. The current stock performance of TopBuild shows a 52-week-high of $280.67 and a 52-week-low of $140.93. Moreover, at the end of the last trading period, the closing price was at $273.93.
For Installed Building Products Inc IBP, Seaport Global initiated coverage, by setting the current rating at Buy. Installed Building Prods earned $2.15 in the first quarter, compared to $1.54 in the year-ago quarter. The current stock performance of Installed Building Prods shows a 52-week-high of $150.88 and a 52-week-low of $75.45. Moreover, at the end of the last trading period, the closing price was at $148.02.
With a Equal-Weight rating, Morgan Stanley initiated coverage on Vivid Seats Inc SEAT. The price target seems to have been set at $9.50 for Vivid Seats. Vivid Seats earned $0.15 in the first quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $9.89 and a 52-week-low of $6.29. At the end of the last trading period, Vivid Seats closed at $8.33.
With a Buy rating, B. Riley Securities initiated coverage on Lilium NV LILM. The price target seems to have been set at $3.00 for Lilium. NoneThe stock has a 52-week-high of $3.25 and a 52-week-low of $0.37. At the end of the last trading period, Lilium closed at $1.37.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.